| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2003-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fcebd05a9e618577ea186c54bddfda9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78c0a740fdd1c175fa633f0e44035712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3248e0448b72a03f90bf2b081d38bac |
| publicationDate |
2008-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7329642-B2 |
| titleOfInvention |
β-2-glycoprotein is an inhibitor of angiogenesis |
| abstract |
The present disclosure provides a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked β2-Glycoprotein 1 (β2GP1) to cells associated with the tissue. The presence of β2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. The disclosure also provides a method for treating tumors by providing β2GP1 to the tumor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293522-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017284975-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009226887-A1 |
| priorityDate |
2002-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |